SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001176256-16-000708
Filing Date
2016-11-23
Accepted
2016-11-23 15:07:39
Documents
9
Period of Report
2016-11-23

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN ISSUER FOR THE MONTH OF NOVEMBER 2016 nymox6knomrdmpm.htm 6-K 5647
2 NOTICE OF MEETING AND RECORD DATE FOR DECEMBER 14, 2016 exhibit99-1.htm EX-99.1 5423
3 NOTICE OF MEETING exhibit99-2.htm EX-99.2 6160
4 MANAGEMENT PROXY CIRCULAR exhibit99-3.htm EX-99.3 113804
5 FORM OF PROXY exhibit99-4.htm EX-99.4 21547
6 cpulogo.jpg GRAPHIC 4237
7 exhibit99-1x1x1.jpg GRAPHIC 3447
8 exhibit99-4x1x1.jpg GRAPHIC 12567
9 exhibit99-4x1x2.jpg GRAPHIC 5636
  Complete submission text file 0001176256-16-000708.txt   189794
Mailing Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2
Business Address 9900 CAVENDISH BLVD., SUITE 306 ST. LAURENT QUEBEC CANADA A8 H4M 2V2 1-800-936-9669
NYMOX PHARMACEUTICAL CORP (Filer) CIK: 0001018735 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-12033 | Film No.: 162016356
SIC: 2835 In Vitro & In Vivo Diagnostic Substances